HopeStage
Back to all studies
CompletedNCT00363298

Dextroamphetamine or comparison treatment added for treatment-resistant OCD

About this titleRead the official source — NCT00363298
Medication studyAges 18–55United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
StanfordSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2006
Recruitment status
Completed
Enrollment listed in the registry
24
Sponsor
Stanford University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT00363298
Official title
Show the full official title

Double-blind Trial of Acute and Intermediate-term Dextro-amphetamine Versus Caffeine Augmentation in Treatment Resistant Obsessive Compulsive Disorder (OCD)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Stanford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Stanford University, a university.

Did this study involve medication?

Yes. The study involved medication, including dextro-amphetamine and Sham Comparison.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies